HIGHLIGHTS
- who: Windows User from the Institute of Pharmacy, Jhalwa, Prayagraj, Uttar Pradesh, India, have published the research: GSC Biological and Pharmaceutical Sciences, in the Journal: (JOURNAL)
- what: Mefenamic acid, a BCS class II drug gives a reason to improve its solubility and by studying about its formulations it gives major goal for formulation development of modified drug delivery system such as Nanocrystals, Nanostructured lipid carriers etc. for improved bioavailability of the drug at desired site of action.
SUMMARY
Mefenamic acid (MA) is an anthranilic acid derivative. Because of short half-life . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.